Dana-Farber Cancer Institute at Faulkner Hospital

Boston, Massachusetts 02130

0 studies enrolling now · 4 studies all time

What they study most

Breast Cancer

Studies at this site

• T-DM1 vs Paclitaxel/Trastuzumab for Breast (ATEMPT Trial) — Completed
• Eribulin in HER2 Negative Metastatic BrCa — Completed
• BKM120 For Triple Negative Breast Cancer — Completed
• Cabozantinib for Metastatic Triple Negative BrCa — Completed